Red cell size and the clinical and haematological features of homozygous sickle cell disease

British Journal of Haematology
G R SerjeantB E Serjeant

Abstract

The contribution of red cell size (mean cell volume) to the clinical and haematological manifestations of homozygous sickle cell (SS) disease has been investigated by comparing the features of two groups of patients with low (less than or equal to 80 fl) and high (greater than 95 fl) MCV values after matching for age, sex and fetal haemoglobin level. The microcytic group manifested significantly higher Hb, PCV, RBC and HbA2 levels and significantly lower reticulocyte and irreversibly sickled-cell counts. Clinical features were not less severe in the microcytic group, splenomegaly persisting for longer and painful crises were more common although the latter difference did not reach significance. The milder haematological picture associated with decreased intravascular sickling was not reflected in a more mild clinical course. It is postulated that the higher viscosity accompanying the higher haemoglobin levels in microcytic patients may offset the rheological advantages of decreased intravascular sickling.

References

Feb 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R L NagelK Matsutomo
Jun 1, 1977·British Journal of Haematology·D P MillardG R Serjeant
Jan 1, 1981·The British Journal of Ophthalmology·R J HayesG R Serjeant
Dec 12, 1959·Nature·K BETKEI SCHLICHT
Mar 1, 1962·Journal of Clinical Pathology·R N BEALER F TAYLOR

❮ Previous
Next ❯

Citations

Feb 4, 1982·The New England Journal of Medicine·S H EmburyW C Mentzer
Feb 4, 1982·The New England Journal of Medicine·A N Schechter, H F Bunn
Apr 1, 1986·American Journal of Hematology·P F MilnerJ T Wilson
Jan 1, 1984·Clinical and Laboratory Haematology·S DaviesM Brozovic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.